Marc Hedrick, MD is the President and CEO of Plus Therapeutics, a clinical-stage pharmaceutical company focused on developing targeted radiotherapeutics.
Marc Hedrick, MD is the President and CEO of Plus Therapeutics, a clinical-stage pharmaceutical company focused on developing targeted radiotherapeutics for central nervous system cancers. He has held this role since June 2019 and is based in Austin, Texas. Hedrick is a medical doctor who leads the company's efforts in treating difficult-to-treat cancers in adults and children.
Full founder directory · Investor directory · Company funding database · Fundraising library